References
- Ogata T, Yasaka M, Wakugawa Y, Inoue T, Ibayashi S, Okada Y. Deep venous thrombosis after acute intracerebral hemorrhage. J Neurol Sci 2008;272:83–6.
- Hamilton MG, Hull RD, Pineo GF. Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery 1994;34:280–96. discussion 296.
- Kim KS, Brophy GM. Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage. Neurocrit Care 2009;11:28–33.
- Skrifvars MB, Bailey M, Presneill J, et al. Venous thromboembolic events in critically ill traumatic brain injury patients. Intensive Care Med 2017;43:419–28.
- Bahloul M, Chaari A, Kallel H, et al. Pulmonary embolism in intensive care unit: predictive factors, clinical manifestations and outcome. Ann Thorac Med 2010;5:97–103.
- Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 2013;18:129–38.
- Hemphill JC, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015;46:2032–60.
- Brain Trauma Foundation. https://braintrauma.org/guidelines/guidelines-for-the-management-of-severe-tbi-4th-ed#/ [accessed 22 Oct 2020].
- Matsushima K, Inaba K, Cho J, et al. Therapeutic anticoagulation in patients with traumatic brain injury. J Surg Res 2016;205:186–91.
- Divito A, Kerr K, Wilkerson C, Shepard S, Choi A, Kitagawa RS. Use of anticoagulation agents after traumatic intracranial hemorrhage. World Neurosurg 2019;123:e25–e30.
- Byrnes MC, Irwin E, Roach R, James M, Horst PK, Reicks P. Therapeutic anticoagulation can be safely accomplished in selected patients with traumatic intracranial hemorrhage. World J Emerg Surg 2012;7:25.
- Schleyer AM, Robinson E, Dumitru R, et al. Preventing hospital-acquired venous thromboembolism: improving patient safety with interdisciplinary teamwork, quality improvement analytics, and data transparency. J Hosp Med 2016;11:S38–S43.
- StataCorp. 2017. Stata Statistical Software: Release 15. College Station (TX): StataCorp LLC.
- Ottosen TP, Grijota M, Hansen ML, et al. Use of antithrombotic therapy and long-term clinical outcome among patients surviving intracerebral hemorrhage. Stroke 2016;47:1837–43.
- Murphy MP, Kuramatsu JB, Leasure A, et al. Cardioembolic stroke risk and recovery after anticoagulation-related intracerebral hemorrhage. Stroke 2018;49:2652–8.
- Biffi A, Kuramatsu JB, Leasure A, et al. Oral anticoagulation and functional outcome after intracerebral hemorrhage. Ann Neurol 2017;82:755–65.
- Murthy SB, Gupta A, Merkler AE, et al. Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis. Stroke 2017;48:1594–600.
- Majeed A, Kim Y-K, Roberts RS, Holmström M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 2010;41:2860–6.
- Claassen DO, Kazemi N, Zubkov AY, Wijdicks EFM, Rabinstein AA. Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol 2008;65:1313–8.
- Flint AC, Lingamneni R, Rao VA, et al. Risks of thrombosis and rehemorrhage during early management of intracranial hemorrhage in patients with mechanical heart valves. J Am Coll Cardiol 2015;66:1738–9.
- Wilson D, Ambler G, Shakeshaft C, et al. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol 2018;17:539–47.